Yanting Shi
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Glycosylation and Glycoproteins Research
Papers in
-
- RNA modifications and cancer 4
- Glycosylation and Glycoproteins Research 2
- Genetics 6
- Inflammatory Bowel Disease 6
- Co-authors
- Genwen Chen (3 shared papers)Jianyong Sun (2 shared papers)Mengmeng Liu (1 shared paper)Yu Zhang (1 shared paper)Jie Liang (13 shared papers)Mingzuo Jiang (4 shared papers)Nan Wu (4 shared papers)Xiaoliang Gao (4 shared papers)
- Journals
- Frontiers in Pharmacology (2 papers)Frontiers in Oncology (2 papers)Theranostics (2 papers)Scientific Reports (2 papers)Frontiers in Medicine (2 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Yanting Shi
29 papers receiving 800 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 395
- Molecular Biology 544
- Pulmonary and Respiratory Medicine 92
- Immunology 56
- Oncology 61
Countries citing papers authored by Yanting Shi
This map shows the geographic impact of Yanting Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanting Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanting Shi more than expected).
Fields of papers citing papers by Yanting Shi
This network shows the impact of papers produced by Yanting Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanting Shi. The network helps show where Yanting Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanting Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 250 | |
| 2 | 2019 | 128 | |
| 3 | 2017 | 106 | |
| 4 | 2022 | 56 | |
| 5 | 2020 | 52 | |
| 6 | 2023 | 42 | |
| 7 | 2022 | 28 | |
| 8 | 2023 | 19 | |
| 9 | 2023 | 15 | |
| 10 | 2024 | 14 | |
| 11 | 2022 | 10 | |
| 12 | 2020 | 10 | |
| 13 | 2024 | 9 | |
| 14 | 2022 | 9 | |
| 15 | 2023 | 8 | |
| 16 | 2023 | 8 | |
| 17 | 2021 | 8 | |
| 18 | 2023 | 8 | |
| 19 | 2025 | 6 | |
| 20 | 2024 | 5 |
About Yanting Shi
Yanting Shi is a scholar working on Molecular Biology, Genetics, Epidemiology, Cancer Research and Nephrology, having authored 35 papers that have together received 808 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (6 papers), Microscopic Colitis (4 papers), RNA modifications and cancer (4 papers), Acute Kidney Injury Research (3 papers), Cancer-related molecular mechanisms research (3 papers), Ferroptosis and cancer prognosis (2 papers), Glycosylation and Glycoproteins Research (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (395 citations), Molecular Biology (544 citations), Pulmonary and Respiratory Medicine (92 citations), Immunology (56 citations) and Oncology (61 citations). Yanting Shi has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Genwen Chen, Jianyong Sun, Mengmeng Liu, Yu Zhang, Jie Liang, Mingzuo Jiang, Nan Wu, Xiaoliang Gao, Song Su and Wenjiao Li. Their work appears in journals such as Frontiers in Pharmacology, Frontiers in Oncology, Theranostics, Scientific Reports and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.